Aclaris Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Aclaris Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2024.
  • Aclaris Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 71.4M shares, a 0.85% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 71.4M +599K +0.85% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 71.3M +563K +0.8% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 71.2M +4.04M +6.01% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 70.9M +4.21M +6.31% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 70.8M +4.14M +6.21% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 70.8M +4.1M +6.15% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 67.2M +5.47M +8.86% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 66.7M +5.46M +8.92% Dec 31, 2022 10-K 2024-02-27
Q3 2022 66.7M +5.45M +8.91% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 66.7M +5.46M +8.93% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 61.7M +9.66M +18.5% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 61.2M +16.1M +35.7% Dec 31, 2021 10-K 2023-02-23
Q3 2021 61.2M +18.3M +42.7% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 61.2M +18.5M +43.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 52.1M +10.2M +24.5% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 45.1M +3.62M +8.74% Dec 31, 2020 10-K 2022-02-24
Q3 2020 42.9M +1.54M +3.71% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 42.7M +1.41M +3.42% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 41.8M +563K +1.36% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 41.5M +275K +0.67% Dec 31, 2019 10-K 2021-02-25
Q3 2019 41.4M +10.4M +33.5% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 41.3M +10.3M +33.3% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 41.3M +10.4M +33.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 41.2M +10.4M +33.6% Dec 31, 2018 10-K 2020-02-25
Q3 2018 31M +156K +0.51% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 31M +4.23M +15.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 30.9M +4.81M +18.4% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 30.9M +4.8M +18.4% Dec 31, 2017 10-K 2019-03-18
Q3 2017 30.8M +9.41M +43.9% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 26.7M +5.33M +24.9% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 26.1M +5.78M +28.5% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 26.1M +5.9M +29.3% Dec 31, 2016 10-K 2018-03-12
Q3 2016 21.4M +18.7M +685% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 21.4M Jun 30, 2016 10-Q 2016-08-11
Q1 2016 20.3M Mar 31, 2016 10-Q 2016-05-11
Q4 2015 20.2M +17.4M +638% Dec 31, 2015 10-K 2017-03-15
Q3 2015 2.73M Sep 30, 2015 10-Q/A 2015-12-03
Q4 2014 2.73M Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.